Randomized study of the effects of Aerochamber Plus® Flow-Vu® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease

This study compared the efficacy, pharmacokinetics (PK), and safety of GFF MDI (Bevespi Aerosphere®), a fixed-dose combination of glycopyrronium and formoterol fumarate dihydrate (14.4/10 μg) delivered by a metered dose inhaler (MDI) formulated using innovative co-suspension delivery technology, in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Respiratory medicine 2018-05, Vol.138, p.74-80
Hauptverfasser:	Fakih, Faisal, Spangenthal, Selwyn, Sigal, Barry, Darken, Patrick, Maes, Andrea, Siddiqui, Shahid, Gillen, Michael, Reisner, Colin, Martin, Ubaldo J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Bronchodilator Agents - administration & dosage Bronchodilator Agents - adverse effects Bronchodilator Agents - blood Bronchodilators Chlorofluorocarbons Chronic obstructive pulmonary disease Co-suspension delivery technology Concentration time Confidence intervals Drug Combinations Drug dosages Evidence-based medicine Female Forced Expiratory Volume - drug effects Formoterol Formoterol Fumarate - administration & dosage Formoterol Fumarate - adverse effects Formoterol Fumarate - blood Formoterol fumarate dihydrate Glycopyrrolate Glycopyrrolate - administration & dosage Glycopyrrolate - adverse effects Glycopyrrolate - blood Glycopyrronium Humans Inhalation Spacers Inhalers Lung diseases Male Metered dose inhaler Metered Dose Inhalers Middle Aged Muscarinic Antagonists - administration & dosage Muscarinic Antagonists - adverse effects Muscarinic Antagonists - blood Obstructive lung disease Patients Pharmacokinetics Pharmacology Pulmonary Disease, Chronic Obstructive - blood Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - physiopathology Randomization Safety Severity of Illness Index Spacer Valved holding chamber
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!